Acta Pharmacologica et Toxicologica · 1971 · 30 citations · 3 references
MedicinePharmacokineticsPharmacologyDrug MetabolismExperimental PharmacologyNeuropharmacologyDrug DispositionDrug DistributionDrug ExcretionDrug Release From Dosage FormsIn Vitro PharmacologySpecies Differences In Drug MetabolismDepot EffectPharmacokinetics Of Neuroactive DrugsPharmacokinetics Of Subcutaneous AdministrationSustained Release Kinetics
The metabolism of flupenthixol decanoate administered in viscoleo® by intramuscular or subcutaneous injection has been studied by thin‐layer chromatographic techniques after extraction of urine, faeces and organs from dogs and rats. Since only minute amounts of the compound itself were detected in the organs and a high hydrolytic activity of blood and organs was demonstrated by in vitro experiments, it was concluded that the compound is hydrolyzed in the organism. The flupenthixol thus formed was found to be metabolized by sulphoxidation and by dealkylation in the side chain following the same pattern as that previously shown for flupenthixol. The neuroleptic effect seen in the pharmacological studies is presumably due to flupenthixol, since this is quantitatively by far the most important substance found in brain extracts. In order to study the depot effect of the preparation, blood levels and excretion were followed after administration of the 3 H‐labelled compound. These studies indicated, that a sustained release of drug from a depot was obtained. The presence of a relatively limited depot was demonstrated.
3
Metabolism, Distribution and Excretion of Flupenthixol
Aksel Jørgensen, Villy Hansen, U. D. Larsen et al. · Acta Pharmacologica et Toxicologica · 1969 · 27 citations